ATEA PHARMACEUTICALS

Serial Number 98904504
686

Registration Progress

Application Filed
Dec 16, 2024
Under Examination
Approved for Publication
Jul 8, 2025
Published for Opposition
Jul 8, 2025
Registered

Attorney Assistance

Notice of Publication
Due: Aug 07, 2025 13 days

Trademark Image

ATEA PHARMACEUTICALS

Basic Information

Serial Number
98904504
Filing Date
December 16, 2024
Published for Opposition
July 8, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
686
Status Date
Jul 8, 2025
Application
Pending
Classes
005

Rights Holder

Atea Pharmaceuticals, Inc.

03
Address
225 Franklin Street, Suite 2100
Boston, MA 02110

Ownership History

Atea Pharmaceuticals, Inc.

Original Applicant
03
Boston, MA

Atea Pharmaceuticals, Inc.

Owner at Publication
03
Boston, MA

Legal Representation

Attorney
Theodore H. Davis Jr.

USPTO Deadlines

Next Deadline
13 days remaining
Notice of Publication
Due Date
August 07, 2025
Extension Available
Until September 07, 2025
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

13 events
Date Code Type Description Documents
Jul 8, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 8, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 2, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 6, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 6, 2025 IUAA P USE AMENDMENT ACCEPTED Loading...
Jun 3, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
May 22, 2025 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
May 22, 2025 TAEA I TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED Loading...
Mar 31, 2025 EAAU I TEAS AMENDMENT OF USE RECEIVED Loading...
Mar 31, 2025 AUPC I AMENDMENT TO USE PROCESSING COMPLETE Loading...
Mar 31, 2025 IUAF S USE AMENDMENT FILED Loading...
Dec 16, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 16, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, anti-virals
First Use Anywhere: Mar 28, 2025
First Use in Commerce: Mar 28, 2025

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMACEUTICALS"